Cirrhosis/Liver Failure News

PARIS — Patients with cirrhosis who experienced a multi-drug resistant bacterial infection were less likely to respond to first-line treatment and resolve infection and had a significantly higher risk for in-hospital mortality, according to a presentation at the International Liver Congress.

PARIS — Beginning Wednesday, April 11, Healio Gastroenterology and Liver Disease will provide live coverage from the International Liver Congress 2018.

NGA2F glycan levels present on perfusate proteins of liver grafts correlated with the development of primary nonfunction in patients who underwent liver transplantation, according to recently published data.

The Ascites-Q symptom assessment questionnaire demonstrated superior validity compared with two other ascites-specific questionnaires, according to recently published data.

Diet and lifestyle play a large role in liver health. Lately, researchers have made several important discoveries regarding the ties between diet and the gut microbiome, and identified specific dietary components that either have protective qualities for liver health or increase the risk for liver disease and cancer.

U.S. adults consumed approximately 470 binge drinks per drinker in 2015 for a total of 17.5 billion binge drinks, according to findings recently published in the American Journal of Preventive Medicine.

Acute-on-chronic liver failure grade was a significant determinant of response to terlipressin and albumin among patients treated for type 1 hepatorenal syndrome, according to a recently published study.

Fibroblast growth factor 21 levels predicted the presence and development of acute-on-chronic liver failure in patients admitted to intensive care unit for acute decompensated cirrhosis, according to a recently published study.

Myosteatosis, low BMI and low alanine aminotransferase levels correlate with skeletal volume loss in patients with chronic liver disease, especially among women, according to recently published data.

Specialized chronic disease management for patients with chronic liver disease demonstrated high potential to be more cost-effective than standard care due to fewer patient deaths, according to recently published data.